Literature DB >> 18427125

Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.

Victoria L Vetter, Josephine Elia, Christopher Erickson, Stuart Berger, Nathan Blum, Karen Uzark, Catherine L Webb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18427125     DOI： 10.1161/CIRCULATIONAHA.107.189473

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  83 in total

1.  Late potentials in the signal-averaged electrocardiogram in pre-pubertal children with ADHD, before and after methylphenidate treatment.

Authors:  Eitan Nahshoni; Pavel Golubchik; Jonathan Glazer; Jonathan Sever; Boris Strasberg; Shula Imbar; Gal Shoval; Abraham Weizman; Gil Zalsman
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-12-11       Impact factor: 4.785

2.  Guanfacine Extended-Release Tablets (Intuniv), a Nonstimulant Selective Alpha(2A)-Adrenergic Receptor Agonist For Attention-Deficit/Hyperactivity Disorder.

Authors:  Martin P Cruz
Journal:  P T       Date:  2010-08

3.  Systems pharmacology of arrhythmias.

Authors:  Seth I Berger; Avi Ma'ayan; Ravi Iyengar
Journal:  Sci Signal       Date:  2010-04-20       Impact factor: 8.192

Review 4.  An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults.

Authors:  Timothy E Wilens; Nicholas R Morrison; Jefferson Prince
Journal:  Expert Rev Neurother       Date:  2011-10       Impact factor: 4.618

5.  Mortality in children and adolescents prescribed antipsychotic medication: a retrospective cohort study using the UK general practice research database.

Authors:  Fariz A Rani; Patrick Byrne; Noel Cranswick; Macey L Murray; Ian C K Wong
Journal:  Drug Saf       Date:  2011-09-01       Impact factor: 5.606

Review 6.  Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.

Authors:  Marc De Hert; Johan Detraux; Ruud van Winkel; Weiping Yu; Christoph U Correll
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

7.  Cardiac risk assessment before the use of stimulant medications in children and youth.

Authors:  S A Bélanger; A E Warren; R M Hamilton; C Gray; R M Gow; S Sanatani; J M Côté; J Lougheed Frcpc; J Leblanc; S Martin; B Miles; C Mitchell; D A Gorman; M Weiss; R Schachar
Journal:  Paediatr Child Health       Date:  2009-11       Impact factor: 2.253

8.  Pharmacologic intervention for attention-deficit hyperactivity disorder in preschoolers : is it justified?

Authors:  Jaswinder K Ghuman; Harinder S Ghuman
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

9.  Update on adult attention-deficit/hyperactivity disorder.

Authors:  Paul Hammerness; Craig Surman; Katherine Miller
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

Review 10.  Sudden Cardiac Death in the Young.

Authors:  Michael Ackerman; Dianne L Atkins; John K Triedman
Journal:  Circulation       Date:  2016-03-08       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.